Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 22,412 shares at $35.28 ($788K) on 2021-02-10, disclosed to the SEC on 2021-02-10.
Open-market sale of $788k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.03 | 3,313 | $116K | 14.7% |
| 2 | $35.03 | 3,313 | $116K | 14.7% |
| 3 | $35.21 | 5,963 | $210K | 26.6% |
| 4 | $35.21 | 5,963 | $210K | 26.6% |
| 5 | $35.28 | 1,930 | $68K | 8.6% |
| 6 | $35.28 | 1,930 |
| $68K |
| 8.6% |
| Total | $35.17 avg | 22,412 | $788K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |